CLINICAL_TRIALS
trial_result
· 2023-10-06
Clinical Trial Update: A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved. [Phase 3]
Summary
A Phase 3 trial comparing safety and immunogenicity of rabies pre-exposure prophylaxis regimens approved by Government of India versus WHO; current status unkno…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kempegowda Institute of Medical Sciences, Bangalore | Conditions: Vaccine Reaction | Phase 3 | Status: UNKNOWN